• 1. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 2. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 5. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267

Methyl 2-Fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate (CAS No. 1261894-17-0): A Comprehensive Overview

Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate (CAS No. 1261894-17-0) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its unique structural and chemical properties, has been the subject of extensive studies due to its potential applications in drug development and therapeutic interventions.

The molecular structure of Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate consists of a benzoate core substituted with fluorine and hydroxyl groups at specific positions. This arrangement imparts distinct electronic and steric properties to the molecule, making it a promising candidate for various biological and chemical interactions. The presence of both fluoro and hydroxy functional groups enhances its reactivity and binding affinity, which are crucial factors in the design of novel therapeutic agents.

In recent years, the pharmaceutical industry has witnessed a surge in the exploration of fluorinated compounds due to their enhanced metabolic stability, bioavailability, and binding affinity to biological targets. The incorporation of fluorine atoms into molecular structures often leads to improved pharmacokinetic profiles, making such compounds more effective in clinical settings. Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate, with its dual fluorine and hydroxyl substituents, exemplifies this trend and represents a significant advancement in the quest for innovative drug candidates.

One of the most compelling aspects of Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate is its potential role in addressing various therapeutic challenges. Researchers have been particularly interested in its interactions with enzymes and receptors involved in critical biological pathways. For instance, studies have suggested that this compound may exhibit inhibitory effects on certain enzymes implicated in inflammation and oxidative stress, which are key factors in conditions such as arthritis and neurodegenerative diseases.

The synthesis of Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate involves multi-step organic reactions that require precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, including palladium-catalyzed cross-coupling reactions and fluorination techniques, have been employed to achieve the desired molecular structure efficiently. These synthetic strategies not only highlight the compound's complexity but also underscore the advancements in synthetic organic chemistry that enable the production of such intricate molecules.

The pharmacological properties of Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate have been investigated through both in vitro and in vivo studies. Preliminary findings indicate that this compound demonstrates notable activity against several disease models, including cancer cell lines and inflammatory conditions. The exact mechanisms by which it exerts its effects are still under investigation, but preliminary data suggest that its interaction with biological targets may involve modulation of signaling pathways associated with cell proliferation, survival, and apoptosis.

In the realm of drug discovery, computational modeling has played an increasingly important role in predicting the biological activity of novel compounds like Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate. By leveraging advanced computational techniques such as molecular docking and virtual screening, researchers can rapidly assess the potential interactions between this compound and various biological targets. These computational approaches not only accelerate the drug discovery process but also provide valuable insights into the structural features that contribute to its pharmacological effects.

The future prospects for Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate are promising, with ongoing research aimed at optimizing its pharmacological profile and exploring new therapeutic applications. Collaborative efforts between academic institutions, pharmaceutical companies, and biotechnology firms are essential to translate these findings into tangible clinical benefits for patients worldwide. As our understanding of complex biological systems continues to evolve, compounds like this will undoubtedly play a pivotal role in shaping the future of medicine.

In conclusion, Methyl 2-fluoro-4-(3-fluoro-4-hydroxyphenyl)benzoate (CAS No. 1261894-17-0) represents a significant advancement in pharmaceutical chemistry with its unique structural features and promising biological activities. The ongoing research into this compound not only highlights the importance of fluorinated molecules in drug development but also underscores the interdisciplinary nature of modern medicinal research. As we continue to uncover new insights into its pharmacological properties, it is clear that this compound holds great potential for addressing some of the most pressing health challenges faced by society today.

• 1261900-28-0(Methyl 4-fluoro-4'-hydroxybiphenyl-3-carboxylate)
• 1214324-64-7(Methyl 2-fluoro-3-hydroxybenzoate)
• 1261945-94-1(Methyl 4-(3-fluoro-4-hydroxyphenyl)benzoate)
• 1261918-51-7(Methyl 4-fluoro-3-(4-fluoro-3-hydroxyphenyl)benzoate)
• 1261897-71-5(Methyl 3-(3-fluoro-4-hydroxyphenyl)benzoate)
• 1261971-78-1(Methyl 2-fluoro-5-(4-fluoro-3-hydroxyphenyl)benzoate)
• 1261894-12-5(2-Fluoro-4-(2-fluoro-4-methoxycarbonylphenyl)phenol)
• 1261984-96-6(Methyl 3-fluoro-5-(3-fluoro-4-hydroxyphenyl)benzoate)
• 1261894-21-6(Methyl 2-fluoro-4-(4-fluoro-3-hydroxyphenyl)benzoate)
• 1261894-23-8(3-Fluoro-4-(3-fluoro-4-methoxycarbonylphenyl)phenol)